Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP982428.RAS_rVzqWUcnLTU2q6uvpcbBBJ9lp_N3W-TE0K6cGTlG0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP982428.RAS_rVzqWUcnLTU2q6uvpcbBBJ9lp_N3W-TE0K6cGTlG0130_assertion type Assertion NP982428.RAS_rVzqWUcnLTU2q6uvpcbBBJ9lp_N3W-TE0K6cGTlG0130_head.
- NP982428.RAS_rVzqWUcnLTU2q6uvpcbBBJ9lp_N3W-TE0K6cGTlG0130_assertion wasGeneratedBy ECO_0000203 NP982428.RAS_rVzqWUcnLTU2q6uvpcbBBJ9lp_N3W-TE0K6cGTlG0130_provenance.
- NP982428.RAS_rVzqWUcnLTU2q6uvpcbBBJ9lp_N3W-TE0K6cGTlG0130_assertion wasDerivedFrom befree-2016 NP982428.RAS_rVzqWUcnLTU2q6uvpcbBBJ9lp_N3W-TE0K6cGTlG0130_provenance.
- NP982428.RAS_rVzqWUcnLTU2q6uvpcbBBJ9lp_N3W-TE0K6cGTlG0130_assertion SIO_000772 22587422 NP982428.RAS_rVzqWUcnLTU2q6uvpcbBBJ9lp_N3W-TE0K6cGTlG0130_provenance.
- NP982428.RAS_rVzqWUcnLTU2q6uvpcbBBJ9lp_N3W-TE0K6cGTlG0130_assertion evidence source_evidence_literature NP982428.RAS_rVzqWUcnLTU2q6uvpcbBBJ9lp_N3W-TE0K6cGTlG0130_provenance.
- NP982428.RAS_rVzqWUcnLTU2q6uvpcbBBJ9lp_N3W-TE0K6cGTlG0130_assertion description "[The BCR-ABL T315I kinase domain mutation is insensitive to dasatinib therapy for Philadelphia-positive acute lymphoid leukemia (Ph + ALL) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982428.RAS_rVzqWUcnLTU2q6uvpcbBBJ9lp_N3W-TE0K6cGTlG0130_provenance.